Promomed awarded by the Russian Association of Independent Pharmacies for innovative drug for treatment of COVID-19
Promomed 28 April 2021
Russian Association of Independent Pharmacies that unites more than 10,000 pharmacies across the country, recognized Promomed as the winner in the nomination «Innovation of the Year in the treatment of COVID-19» for the development of a anti-coronavirus drug Areplivir.
The Association comments: «We really believe that the creation of Areplivir has fundamentally affected the treatment regimens for coronavirus infection and saved thousands of lives.»
The Association comments: «We really believe that the creation of Areplivir has fundamentally affected the treatment regimens for coronavirus infection and saved thousands of lives.»
The award was presented at the 11th Conference of the Russian Association of Independent Pharmacies in Sochi.
